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The Department of Health and Social Care has recently published their consultation outcome 
regarding the availability of gluten-free foods (GFF) on NHS prescriptions.1 Following an 
unprecedented number of responses from patients, healthcare professionals and professional 
bodies, the Government has decided to continue to provide GFF on prescription but restrict the 
products available to breads and mixes. This favoured option by the majority of consultation 
respondents has now proceeded to formal ratification, through an amendment to the National 
Health Service Regulations 2004, Schedule 1. In this editorial, we discuss the controversies 
that have existed regarding prescription of GFF in coeliac disease where the gluten free diet is 
the treatment, and discuss the future implications that this decision may have on both patients 
and the NHS.   
 
The history of GFF Prescriptions  
GFF products have been available in the UK via prescription for those medically diagnosed 
with coeliac disease for over 50 years, with the aim of supporting dietary adherence and 
reducing complications. In recent years, these prescriptions were restricted to staple foods, 
approved by the Advisory Committee on Borderline Substances (ACBS). The National 
Prescribing Guidelines endorsed by both the Primary Care Society for Gastroenterology and 
the British Dietetic Association set out recommendations to healthcare professionals on the 
quantity of gluten-free staple foods that may be prescribed.2 These allowances (in units) were 
GHWHUPLQHGE\DQLQGLYLGXDO¶VDJHDQGVH[HJPDOH-59 years = 18 units, female 19 - 74 
years = 14 units) and based upon: a) continued consumption of naturally gluten-free foods (e.g. 
potato and rice), b) data from the National Diet and Nutrition Surveys and c) the Eatwell Guide 
for balanced eating.2  
 
These guidelines, first launched in 2004 offer equitable allowances for all UK patients, 
however costs to individuals vary. In England people with coeliac disease pay prescription 
charges (unless they meet exemption criteria), whilst prescriptions in Scotland, Northern 
Ireland and Wales are free. This method of support differs to some other countries where 
government subsidies (e.g. Italy, Argentina) or tax deductibility of excess costs (e.g. USA, 
Canada) are being used.3 4 
 
Recent controversies in GFF Prescriptions and Fake News 
In 2014 NHS PrescQIPP raised concerns that the annual cost of prescriptions for GFF products 
in England was £24.7 million.5 Recommendations were made to restrict prescriptions to 8 units 
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of bread and flour only, with the ambition of saving potentially £10 million.5 This started a 
trend for restricting access to GFF on prescription by a number of clinical commissioning 
groups (CCGs). A geographical variation in care subsequently developed within England, that 
differed to NHS practices in Scotland, Northern Ireland and Wales where National Prescribing 
Guidelines are still followed.  
 
These local decisions and concerns about the variation in GF prescribing policies were widely 
discussed in both the medical literature and the national press.6 These included concerns about 
the cost of GFF products, NHS procurement practices and the appropriate use of a general 
SUDFWLWLRQHU¶Vtime in prescribing GFF products. In relation to costs the Daily Mail ran a front-
page headline on the 17th August 2015 deriding a £116 million spend on gluten free junk food 
on prescription. This article fuelled further misconceptions about GFF prescriptions and was 
later retracted due to significant factual inaccuracies (true spend - £26.8 million on staple food 
items only).7   
 
What was the Department of Health & Social Care consultation? 
A national public consultation was conducted by the Department of Health & Social Care 
between the 31st March and the 22nd June 2017. The consultation suggested that the spend of 
£26.6 million on GFF prescriptions could be redeployed into other areas of the NHS. The NHS 
was unable to enforce restrictions to GFF prescriptions as they lacked statutory authority to do 
so, with prescribing responsibilities laid down in national prescribing legislation that only 
Government could amend., where Views on three options were sought:  1) make no changes 
to GFF prescribing 2) end all GFF prescribing in primary care by adding GFF products to 
Schedule I and 3) restrict to selected GFF products (namely bread and mixes) on prescription.  
 
Holding a national consultation on the issue was supported by both NHS England and clinical 
commissioners. Lauren Hughes, Director of Clinical Policy and Operations, NHS England 
VWDWHG³7KHSXUSRVHRIWKLVUHYLHZLVWRGHYHORSJXLGDQFHDWDQDWLRQDOOHYHOWKDWZLOOVXSSRUW
CCGs locally to manage their resources and reduce the differing approaches and regional 
variation in prescribing across England. Julie Wood, Chief Executive, NHS Clinical 
&RPPLVVLRQHUVVDLGLQ0DUFK³+DYLQJQDWLRQDOVXSSRUWIURP1+6(QJODQGDQGWKH'+ 
(Department of Health) for those local decisions means there will be more consistency and 
UHGXFHYDULDWLRQIRUSDWLHQWV´ 
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The health mLQLVWHU¶V preference following the consultation was to continue GFF on 
prescription but restrict products to breads and flour mixes. Key themes considered included 
accessibility and availability of GFF, cost of GFF, impact on adherence to a gluten-free diet, 
appropriate use of NHS resources, health inequalities, consequences of untreated coeliac 
disease and the potential for system abuse and wastage. The evidence was considered alongside 
the views of key stakeholders including clinicians, commissioners and patients.  
 
The immediate UHVSRQVH WR WKHJRYHUQPHQW¶VGHFLVLRQ on GFF prescribing has been mixed. 
Coeliac UK has welcomed the decision of a national approach to the availability of GFF on 
prescription, whilst a statement from the NHS Clinical Commissioners believes a missed 
opportunity has occurred to release entire GFF spending funds to other frontline NHS services.8 
9
 Although regulations will be put in place to restrict the type of product that can be prescribed, 
Clinical Commissioning Groups will still be able to develop local policies that restrict 
prescribing further. Thus the current scenario of a postcode lottery where some patients are 
able to access prescriptions in line with the national approach while others have effectively no 
access may continue.  
 
Consequences to patients and the NHS 
The long-term sequelae of restricting GFF prescriptions may take many years to reveal 
themselves with regards to patient outcomes. Adherence to a gluten free diet is recognised to 
be difficult for people with coeliac disease, varying between 42-91%, and influenced by access 
to GFF prescriptions.8 A previous NICE health economic analysis estimated that the cost of 
prescribing GFF was £194.24 per patient. This figure represented a low treatment cost for a 
lifelong autoimmune disease, which contrasted treatment costs associated with long term 
complications such as osteoporosis, where an average fracture cost was £27,000.8 Unless the 
newly set out national policy is reflected across England patients may be at risk of long term 
complications.  Only time will tell whether this concern will come to fruition.  
 
Importantly, it should be recognised that this prescription debate has raised the profile of 
coeliac disease -  a lifelong condition affecting 1% of the UK population. The average delay in 
diagnosis is 13 years, with individuals reporting on average 13 consultations with their General 
Practitioner prior to a diagnosis being established.10 In the United Kingdom, three out of four 
cases of coeliac disease remain unrecognised. Medical nihilism has for too long negatively 
influenced the outcomes of people with coeliac disease. Hopefully, through continued working 
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between commissioning groups, patients, stakeholders and clinicians, an optimal use of 
available resources will be achieved, ensuring enhanced outcomes for these patients.  
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